these studies demonstrate that lithium , an agent of proven therapeutic benefit in patients with manic-depressive illness , can affect changes in t4 metabolism and cellular t3 content in neural and anterior pituitary tissue .
C0023870
lithium
C0005586
manic-depressive illness